Reduced carbon monoxide transfer factor (TLCO) in human immunodeficiency virus type I (HIV-I) infection as a predictor for faster progression to AIDS

Nieman, R B; Fleming, J; Coker, R J; Harris, J R; Mitchell, D M
May 1993
Thorax;May1993, Vol. 48 Issue 5, p481
Academic Journal
No abstract available.


Related Articles

  • Coinfection with HTLV-I and HIV: Increase in HTLV-I-Related Outcomes but Not Accelerated HIV Disease Progression? Harrison, Lee H.; Schechter, Mauro // AIDS Patient Care & STDs;Aug98, Vol. 12 Issue 8, p619 

    Reports that human T-lymphotropic virus type I (HTLV-I) and HTLV-II have been postulated to accelerated disease progression in patients coinfected with the human immunodeficiency virus (HIV), but studies suggest that HTLV-II has no effect on HIV disease progression. What HTLV-I is associated...

  • ORAL MANIFESTATION OF PEDIATRIC HIV INFECTION. Neena, I. E.; Edagunji, G. C. // Guident;2011, Vol. 4 Issue 9, p75 

    This review article discusses the oral lesions seen in human immunodeficiency virus which are the early indicators of the acquired immunodeficiency virus. Patients infected with HIV-I frequently demonstrate oral lesions, the earliest clinical signs of HIV infection and disease progression in...

  • The centenary (2015) of the transfer factor for carbon monoxide (TLCO): Marie Krogh's legacy. Hughes, J. Michael B.; Borland, Colin D.R. // Thorax;Apr2015, Vol. 70 Issue 4, p391 

    The author discusses the genesis of birth of single breath transfer factor for carbon monoxide (TLCo.sb) and legacy of scientist Marie Krogh. Topics discussed include TLCO defined as the transfer factor of the lung for carbon monoxide (CO), contribution of circulatory physiologist Seymour Key to...

  • Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study. Rutherford, George W.; Lifson, Alan R.; Hessol, Nancy A.; Darrow, William W.; O'Malley, Paul M.; Buchbinder, Susan P.; Barnhart, J. Lowell; Bodecker, Torsten W.; Cannon, Lyn; Doll, Lynda S.; Holmberg, Scott D.; Harrison, Janet S.; Rogers, Martha F.; Werdegar, David; Jaffe, Harold W. // BMJ: British Medical Journal (International Edition);11/24/90, Vol. 301 Issue 6762, p1183 

    Investigates the progression of HIV-I infection among homosexuals and bisexuals in San Francisco, California. Analysis of the cumulative risk of AIDS by duration of HIV-I infection; Importance of duration of infection to clinical state; Factors affecting disease prevention techniques.

  • Kaposis's sarcoma of the parotid gland in acquired... Mukherjee, Asish; Silver, Carl E.; Rosario, Patrick G.; Gerst, Paul H. // American Surgeon;Mar1998, Vol. 64 Issue 3, p259 

    Presents a case of Kaposi's sarcoma of the parotid in A patient with acquired immunodeficiency syndrome (AIDS). Way in which human immunodeficiency virus-I (HIV-I) entered saliva; Cause of parotid swellings in children with HIV; Part of the body where Kaposi's sarcoma in AIDS patient are...

  • HIV Risk Triples in Women with an STD. Kemper, Carol A. // Infectious Disease Alert;Jul2012, Vol. 31 Issue 10, p117 

    The article discusses research being done on the risk of human immunodeficiency virus (HIV) in women with sexually transmitted disease (STD). It references the studies "Symptomatic Vaginal Discharge Is a Poor Predictor of Sexually Transmitted Infections and Genital Tract Inflammation in...

  • Viral Origins of Human Cancer. Boccardo, E.; Villa, L. L. // Current Medicinal Chemistry;2007, Vol. 14 Issue 24, p2526 

    The first consistent observations that viruses could be associated with some types of cancer where made almost a century ago. Since then researchers have spent a great deal of effort to address the infectious origins of human cancer. As a result of these studies, a strong link between some viral...

  • Mycobacterium tuberculosis/HIV-1 Coinfection and Disease: Role of Human Leukocyte Antigen Variation. Louie, Leslie G.; Hartogensis, Wendy E.; Jackman, Rachael P.; Schultz, Kathleen A.; Zijenah, Lynn S.; Yiu, Carina H.-Y.; Nguyen, Viet D.; Sohsman, Marie Y.; Katzenstein, David K.; Mason, Peter R. // Journal of Infectious Diseases;3/15/2004, Vol. 189 Issue 6, p1084 

    Genetic variation influences immune responses and may contribute to differential development of tuberculosis (TB), particularly in immunosuppressed individuals. To examine the risk of Mycobacterium tuberculosis infection progressing to disease in the context of M. tuberculosis/human...

  • HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation Levels. Eller, Michael A.; Opollo, Marc S.; Liu, Michelle; Redd, Andrew D.; Eller, Leigh Anne; Kityo, Cissy; Kayiwa, Joshua; Laeyendecker, Oliver; Wawer, Maria J.; Milazzo, Mark; Kiwanuka, Noah; Gray, Ronald H.; Serwadda, David; Sewankambo, Nelson K.; Quinn, Thomas C.; Michael, Nelson L.; Wabwire-Mangen, Fred; Sandberg, Johan K.; Robb, Merlin L. // Journal of Infectious Diseases;May2015, Vol. 211 Issue 10, p1574 

    Background. Untreated human immunodeficiency virus type 1 (HIV) infection is associated with persistent immune activation, which is an independent driver of disease progression in European and United States cohorts. In Uganda, HIV-1 subtypes A and D and recombinant AD viruses predominate and...

  • Clinical Manifestations and Predictors of Disease Progression in Drug Users with Human Immunodeficiency Virus Infection.  // New England Journal of Medicine;3/4/93, Vol. 328 Issue 9, p671 

    A correction to the article "Clinical Manifestations and Predictors of Disease Progression in Drug Users with Human Immunodeficiency Virus Infection," in the December 10, 1992 issue is presented.


Read the Article


Sign out of this library

Other Topics